MX2011008857A - Derivados de oxiindol con actividad agonistica del receptor de motilina. - Google Patents
Derivados de oxiindol con actividad agonistica del receptor de motilina.Info
- Publication number
- MX2011008857A MX2011008857A MX2011008857A MX2011008857A MX2011008857A MX 2011008857 A MX2011008857 A MX 2011008857A MX 2011008857 A MX2011008857 A MX 2011008857A MX 2011008857 A MX2011008857 A MX 2011008857A MX 2011008857 A MX2011008857 A MX 2011008857A
- Authority
- MX
- Mexico
- Prior art keywords
- motilin receptor
- agonistic activity
- receptor agonistic
- oxyindole derivatives
- oxyindole
- Prior art date
Links
- PTXVSDKCUJCCLC-UHFFFAOYSA-N 1-hydroxyindole Chemical class C1=CC=C2N(O)C=CC2=C1 PTXVSDKCUJCCLC-UHFFFAOYSA-N 0.000 title abstract 2
- 108700040483 Motilin receptors Proteins 0.000 title abstract 2
- 102000057413 Motilin receptors Human genes 0.000 title 1
- 230000001270 agonistic effect Effects 0.000 title 1
- 102100033818 Motilin receptor Human genes 0.000 abstract 2
- 101001132878 Homo sapiens Motilin receptor Proteins 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20243009P | 2009-02-27 | 2009-02-27 | |
| US28217309P | 2009-12-24 | 2009-12-24 | |
| PCT/JP2010/001368 WO2010098145A1 (en) | 2009-02-27 | 2010-03-01 | Oxyindole derivatives with motilin receptor agonistic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2011008857A true MX2011008857A (es) | 2011-09-30 |
Family
ID=42665356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011008857A MX2011008857A (es) | 2009-02-27 | 2010-03-01 | Derivados de oxiindol con actividad agonistica del receptor de motilina. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8697877B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2401268B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5663743B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101575703B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102317280B (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI1007962A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2750699C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2547415T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2011008857A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2533116C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010098145A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014106238A1 (en) | 2012-12-31 | 2014-07-03 | Fang, Qun, Kevin | Heterocyclic compounds and methods of use thereof |
| EP3063141B1 (en) * | 2013-10-29 | 2018-02-28 | BioMarin Pharmaceutical Inc. | N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors |
| CN106659697B (zh) * | 2014-05-30 | 2022-03-29 | 斯菲叶尔制药私有公司 | 作为抗结核剂的化合物 |
| CA3223173A1 (en) * | 2021-07-30 | 2023-02-02 | Raqualia Pharma Inc. | Crystalline forms |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW355711B (en) | 1992-11-04 | 1999-04-11 | Chugai Pharmaceutical Co Ltd | Erythromycin derivatives |
| JP3449766B2 (ja) | 1993-11-19 | 2003-09-22 | 中外製薬株式会社 | モチリンアンタゴニスト |
| US5767118A (en) | 1994-10-26 | 1998-06-16 | Merck & Co., Inc. | 4-Heterocyclic peperidines promote release of growth hormone |
| JP3901239B2 (ja) | 1996-03-13 | 2007-04-04 | 大正製薬株式会社 | アリールアルカン誘導体 |
| US5734012A (en) | 1996-05-16 | 1998-03-31 | Ohmeda Pharmaceutical Products Division Inc. | Cyclic motilin-like polypeptides with gastrointestinal motor stimulating activity |
| DE19644195A1 (de) | 1996-10-24 | 1998-04-30 | Solvay Pharm Gmbh | 10,13,15-Trioxatricyclo[9.2.1.1.·9·.·6·]-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US6100239A (en) | 1996-11-26 | 2000-08-08 | Chugai Seiyaku Kabushiki Kaisha | 13-membered ring macrolide compound, medicine containing the same, and process for producing the same |
| TWI242011B (en) * | 1997-03-31 | 2005-10-21 | Eisai Co Ltd | 1,4-substituted cyclic amine derivatives |
| US5972939A (en) | 1997-10-28 | 1999-10-26 | Ortho-Mcneil Pharmaceutical, Inc. | Cyclopentene derivatives useful as antagonists of the motilin receptor |
| DE19805822B4 (de) | 1998-02-13 | 2009-02-05 | Solvay Pharmaceuticals Gmbh | 11-Acetyl-12,13-dioxabicyclo[8.2.1]tridecenon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US6165985A (en) | 1998-02-13 | 2000-12-26 | Solvay Pharmaceuticals Gmbh | 11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for their preparation and pharmaceutical compositions comprising them |
| WO2001068622A1 (en) | 2000-03-13 | 2001-09-20 | Ortho-Mcneil Pharmaceutical, Inc. | Novel cyclobutene derivatives useful as antagonists of the motilin receptor |
| WO2001068621A1 (en) | 2000-03-13 | 2001-09-20 | Ortho-Mcneil Pharmaceutical, Inc. | Novel cyclohexene derivatives useful as antagonists of the motilin receptor |
| WO2001068620A1 (en) | 2000-03-13 | 2001-09-20 | Ortho-Mcneil Pharmaceutical, Inc. | Novel cyclopentene derivatives useful as antagonists of the motilin receptor |
| US6511980B2 (en) | 2000-05-05 | 2003-01-28 | Ortho Mcneil Pharmaceutical, Inc. | Substituted diamine derivatives useful as motilin antagonists |
| JP2004529184A (ja) * | 2001-05-10 | 2004-09-24 | ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規１−アミドメチルカルボニル−ピペリジン誘導体、該誘導体を製造するための方法及び中間体並びにこれらの化合物を含有している医薬 |
| JP4928263B2 (ja) | 2003-07-31 | 2012-05-09 | トランザイム・ファーマ | ペプチド結合サロゲートを組み入れた空間的に規定された大環状分子 |
| DE602004030344D1 (de) | 2003-07-31 | 2011-01-13 | Tranzyme Pharma Inc | Räumlich definierte makrocyclische verbindungen, die sich für die entdeckung von arzneimittel eignen |
| US7262195B2 (en) | 2003-09-17 | 2007-08-28 | Bristol-Myers Squibb Company | Compounds useful as motilin agonists and method |
| US7338954B2 (en) | 2003-09-17 | 2008-03-04 | Bristol-Myers Squibb Company | Compounds useful as motilin agonists and method |
| WO2006011035A1 (en) | 2004-07-23 | 2006-02-02 | Glenmark Pharmaceuticals Ltd. | Novel dipeptidyl peptidase iv inhibitors; process for their preparation and compositions containing them |
| AU2006217534B8 (en) * | 2005-02-22 | 2011-12-08 | Pfizer Inc. | Oxyindole derivatives as 5HT4 receptor agonists |
| US7582611B2 (en) | 2005-05-24 | 2009-09-01 | Pfizer Inc. | Motilide compounds |
| WO2007007018A1 (en) | 2005-07-12 | 2007-01-18 | Glaxo Group Limited | Piperazine heteroaryl derivates as gpr38 agonists |
| JO2747B1 (en) | 2005-07-26 | 2014-03-15 | جلاكسو جروب ليمتد | Vehicles |
| EP1757290A1 (en) * | 2005-08-16 | 2007-02-28 | Zentaris GmbH | Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
| PL2041093T3 (pl) | 2006-06-28 | 2010-09-30 | Glaxo Group Ltd | Pochodne piperazynylowe użyteczne w leczeniu zaburzeń, którym pośredniczy receptor GPR38 |
-
2010
- 2010-03-01 JP JP2011536661A patent/JP5663743B2/ja active Active
- 2010-03-01 WO PCT/JP2010/001368 patent/WO2010098145A1/en not_active Ceased
- 2010-03-01 MX MX2011008857A patent/MX2011008857A/es active IP Right Grant
- 2010-03-01 RU RU2011139287/04A patent/RU2533116C2/ru active IP Right Revival
- 2010-03-01 US US13/203,301 patent/US8697877B2/en active Active
- 2010-03-01 CN CN201080007432.5A patent/CN102317280B/zh active Active
- 2010-03-01 ES ES10746028.9T patent/ES2547415T3/es active Active
- 2010-03-01 KR KR1020117021833A patent/KR101575703B1/ko active Active
- 2010-03-01 BR BRPI1007962A patent/BRPI1007962A2/pt not_active IP Right Cessation
- 2010-03-01 EP EP10746028.9A patent/EP2401268B1/en active Active
- 2010-03-01 CA CA2750699A patent/CA2750699C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HK1164318A1 (en) | 2012-09-21 |
| WO2010098145A1 (en) | 2010-09-02 |
| US8697877B2 (en) | 2014-04-15 |
| EP2401268A4 (en) | 2013-01-02 |
| RU2011139287A (ru) | 2013-04-10 |
| US20110312933A1 (en) | 2011-12-22 |
| RU2533116C2 (ru) | 2014-11-20 |
| ES2547415T3 (es) | 2015-10-06 |
| CA2750699A1 (en) | 2010-09-02 |
| BRPI1007962A2 (pt) | 2016-02-23 |
| KR20110133033A (ko) | 2011-12-09 |
| JP2012519153A (ja) | 2012-08-23 |
| EP2401268B1 (en) | 2015-07-29 |
| EP2401268A1 (en) | 2012-01-04 |
| CN102317280A (zh) | 2012-01-11 |
| CA2750699C (en) | 2015-12-29 |
| JP5663743B2 (ja) | 2015-02-04 |
| KR101575703B1 (ko) | 2015-12-10 |
| CN102317280B (zh) | 2014-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2011011428A (es) | Derivados de acido sulfamoilbenzoico como antagonistas de trpm8. | |
| MY149731A (en) | Compounds | |
| JO3078B1 (ar) | مورفولينوثيازولات بصفتها منظمات الوستيرية نوع الفا 7 موجبة | |
| PH12012500622A1 (en) | Compounds for the treatment of dyslipidemia and related diseases | |
| MX2013008431A (es) | Antagonista del receptor de mineralocorticoides. | |
| TN2011000414A1 (en) | Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitors, and uses thereof | |
| PH12012502142A1 (en) | Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities | |
| PH12013502204A1 (en) | 3-spirocyclic piperidine derivatives as ghrelin receptor agonists | |
| MX2014000341A (es) | Novedosos derivados de trifluoro-metil-oxadiazol y su uso en el tratamiento de enfermedades. | |
| MX2012000565A (es) | Derivados de triterpeno tipo lupeol como antivirales. | |
| PH12013501557A1 (en) | Glucagon receptor modulator | |
| GEP20135744B (en) | Quinuclidine carbonate derivatives and medicinal compositions containing the same | |
| MY148948A (en) | Catecholamine derivatives and prodrugs thereof | |
| MX2011008634A (es) | Derivados de aminotetralina composiciones farmaceuticas que los contienen y su uso en terapia. | |
| PH12013500007A1 (en) | Piperidine derivatives and their use for the treatment of metabolic disorders | |
| IN2012DN03182A (cg-RX-API-DMAC7.html) | ||
| JO2645B1 (en) | Vehicles | |
| PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
| IN2012DN01237A (cg-RX-API-DMAC7.html) | ||
| IN2012DN03042A (cg-RX-API-DMAC7.html) | ||
| MX2014000964A (es) | Derivados aza heterociclicos sustituidos. | |
| MX2009009154A (es) | Derivados de espiro-pirano-pirazol. | |
| WO2012135615A3 (en) | Enopeptins, uses thereof, and methods of synthesis thereto | |
| ATE542795T1 (de) | Benzylpiperazinderivate als motilin- rezeptorantagonisten | |
| TN2013000533A1 (en) | Topical ophthalmological pharmaceutical composition containing regorafenib |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |